New study open to recruitment
23 June 2017
WISTERIA: A Phase I trial of WEE1 inhibition with Chemotherapy and Radiotherapy as adjuvant treatment, and a Window of Opportunity trial with Cisplatin in Patients with Head and Neck Cancer
We are delighted to announce that the WISTERIA Trial opened to recruitment yesterday at the Queen Elizabeth Hospital, Birmingham! We are aiming to enroll our first patient into the trial over the upcoming weeks
